Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 7, 2014; 20(41): 15241-15252
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15241
Table 1 General principles for endoscopy in pregnant women1
1Always have a strong indication, particularly in high-risk pregnancies
2Endoscopy should be postponed to second trimester whenever possible
3Lowest effective dose of sedative medications should be used
4Especially category A or B drugs should be used
5Procedure time should be very short
6To avoid vena caval or aortic compression, pregnant women should be positioned in the left pelvic tilt or left lateral position
7Fetal heartbeat should be detected before sedation and also after the endoscopic procedure
8Obstetric support should be available whenever pregnancy-related complications occur
9Placental abruption, imminent delivery, ruptured membranes, or eclampsia are defined as obstetric complications of endoscopy
Table 2 United States food and drug administration categorization of drug safety during pregnancy1
CategoryRiskDescription
ANo risk has been shown in controlled studiesSufficient, well-controlled studies have not demonstrated a risk to the fetus in any trimester of pregnancy
BNo risk in humansSufficient, well-controlled studies have not demonstrated an increased risk of fetal abnormalities despite adverse findings in animals or, in the absence of adequate human studies, animal studies show no fetal risk. The chance of fetal harm is very low but still is a possibility
CRisk cannot be ruled outSufficient, no well-controlled human studies, where animal studies have shown a risk to the fetus. There is a chance of fetal harm if the drug is administered during pregnancy, but the potential benefits should be considered and may outweigh the potential risk
DPositive evidence of riskStudies in humans, or investigational or postmarketing data, have demonstrated fetal risk. Nevertheless, potential benefits from the use of the drug may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or for serious disease for which safer drugs cannot be used or are ineffective
XContraindicated in pregnancyStudies in animals or humans (investigational or postmarketing reports) have demonstrated positive evidence of fetal abnormalities or risk that clearly outweighs any possible benefit to the patient
Table 3 Safety of anesthetics commonly used in gastrointestinal endoscopy
DrugFDA category in pregnancyKey points about drug safety
Narcotics
MeperidineB, but D at termRepeated use of high dose and prolonged administration can cause respiratory depression and seizures
FentanylCIt is safe in low doses
PropofolBGenerally suggested for use in patients who are sedated with difficulty and in complicated clinical situations
General anesthetics
KetamineBData are limited with humans; animal data suggest prolonged use is not safe
Sedatives
DiazepamDSome congenital malformations and mental retardation may be associated with diazepam, the use of diazepam during pregnancy is restricted
MidazolamDAs a benzodiazepine member, its use is restricted during pregnancy, especially in the first trimester
Reversing agents
NaloxoneBIt probably is safe but should be used only in respiratory depression, systemic hypotension, or unresponsiveness in a closely monitored pregnant woman after endoscopy
FlumazenilCFetal risks are unknown, but it should be given carefully in small doses
Table 4 Indications for endoscopy in pregnancy
No.Indication
1Major or continued bleeding
2Severe or refractory nausea and vomiting or abdominal pain
3Dysphagia or odynophagia
4High suspicion of colonic mass
5Severe diarrhea with negative evaluation
6Biliary pancreatitis, CBD stones, or cholangitis
7Biliary or pancreatic ductal injury